Table 1 Clinicopathologic Characteristics of Melanoma Patients.

From: Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis

Variables

Discovery Set, No. (%)

Validation Set, No. (%)

Total, No. (%)

Primary melanoma

Age, y

   ≤60

31 (45.6)

140 (50.2)

171 (49.3)

   >60

37 (54.4)

139 (49.8)

176 (50.7)

Sex

   Male

41 (60.3)

154 (55.2)

195 (56.2)

   Female

27 (39.7)

125 (44.8)

152 (43.8)

Tumor thickness, mm

   ≤1.0

17 (25.0)

102 (36.6)

119 (34.3)

   1.01–2.00

23 (33.8)

70 (25.1)

93 (26.8)

   2.01–4.00

11 (16.2)

50 (17.9)

61 (17.6)

   >4.00

17 (25.0)

57 (20.4)

74 (21.3)

Ulceration

   Absent

53 (77.9)

228 (81.7)

281 (81.0)

   Present

15 (22.1)

51 (18.3)

66 (19.0)

Subtype

   Lentigomaligna

14 (20.6)

59 (21.1)

73 (21.0)

   Superficial spreading

27 (39.7)

104 (37.3)

131 (37.8)

   Nodular

8 (11.8)

44 (15.8)

52 (15.0)

   Acrolentigous melanoma

2 (2.9)

9 (3.2)

11 (3.2)

   Unspecified

17 (25.0)

63 (22.6)

80 (23.0)

Sitea

   Sun-protected

52 (76.5)

199(71.3)

251 (72.3)

   Sun-exposed

16 (23.5)

80 (28.7)

96 (27.7)

Metastatic melanoma

Age, y

   ≤59

24 (52.2)

77 (53.1)

101 (52.9)

   >59

22 (47.8)

68 (46.9)

90 (47.1)

Sex

   Male

33 (71.7)

101 (69.7)

134 (70.2)

   Female

13 (28.3)

44 (30.3)

57 (29.8)

AJCC stage

   I

33 (29.0)

163 (38.4)

196 (36.4)

   II

35 (30.7)

116 (27.4)

151 (28.1)

   III

21 (18.4)

57 (13.4)

78 (14.5)

   IV

25 (21.9)

88 (20.8)

113 (21.0)

  1. AJCC indicates American Joint Committee on Cancer.
  2. aSun-protected sites: trunk, arm, leg, back, and feet; sun-exposed sites: head and neck.